CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation (CAMP) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001736730 · CAMP · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001736730 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
CAMP4 Therapeutics Corporation (NASDAQ: CAMP) has submitted 157 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001736730, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is CAMP4 Therapeutics Corporation's most comprehensive regulatory disclosure. The most recent CAMP4 Therapeutics Corporation 10-K was filed on 2026-03-05 for fiscal year ending 2026. Historical CAMP 10-K annual reports are available from 2018 through 2026.
Investors researching CAMP4 Therapeutics Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CAMP SEC Filings · 8 questionsCAMP4 Therapeutics Corporation (CAMP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 157 filings and access original documents at no cost. CAMP4 Therapeutics Corporation's CIK is 0001736730.